trending Market Intelligence /marketintelligence/en/news-insights/trending/BfPwYJL0470Yv6kKqMC6KA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Intellipharmaceutics receives US, Canadian patents for overdose prevention tech

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Intellipharmaceutics receives US, Canadian patents for overdose prevention tech

Intellipharmaceutics International Inc. received patents from the U.S. Patent and Trademark Office and the Canadian Intellectual Property Office for its overdose prevention technology.

The patents cover aspects of Intellipharmaceutics International's Paradoxical OverDose Resistance Activating System delivery technology, designed to prevent overdose when more pills than prescribed are swallowed intact.

The company plans to incorporate its technology in an alternative product candidate for Rexista, its abuse-deterrent oxycodone hydrochloride extended release tablets that are pending approval from the U.S. FDA.